underpar71,
Just a reminder that Linda Powers is more beholden to what regulators want right now than what investors want right now. NWBO got a reprimand for promoting years ago and so they will not do anything that looks like promotion at all right now. Someone reported that even Specials revenue is not being listed as such because that is too touchy for them to do because regulators don’t want them even hinting at this. You MUST remember that the screening hold was essentially a regulator green light IF and as long as NWBO did not mess up along the way to achieving commercial scale manufacturing and properly submitted BLA/MAA while keeping the pressure off of regulators. NWBO is hog tying themselves because of regulator support which gives regulators the positive attention while NWBO takes the heat so that regulator moves, deliberately slow, are not viewed as favoritism. This is “the process” that satisfies the influence of big pharma profits and keeps NWBO silenced all while patients are sacrificed on the altar of “the process”. Clinicians like Dr. Ashkan and Dr. Linda Liau have expressed their frustrations but also realize what is going on and have been less openly vocal about the slowness of this more recently. They see the consequences of all of this on a daily basis up close and personal. Must be really tough for them to deal with knowing that a life saving treatment is in view but just out of reach for their patients. Glad I am just an investor. Best wishes.
Market Data 
Markets 
AI
